Campath Medication Information
B-cell chronic lymphocytic leukemia (B-CLL) may be treated with the prescription medication Campath® (alemtuzumab). It works by binding to a specific antigen found on the surface of a variety of white blood cells, including leukemia cells. As a result, the immune system attacks the leukemia cells, killing them. Your healthcare provider will administer Campath as an intravenous (IV) infusion, and it will take at least two hours to receive each dosage.
Prior to beginning treatment with Campath, review the drug's safety information with your healthcare provider. Drug interactions are possible, so your healthcare provider needs a complete list of all other medicines you are taking. What's more, you may need to avoid receiving certain vaccinations during treatment with this product.
(Click Campath to learn more about this medication, including information on possible side effects, generic availability, and what to do if you are pregnant or breastfeeding.)